Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer

Sustained HER2/HER3 signaling due to the overproduction of the HER3 ligand heregulin (HRG) is proposed as a key contributor to endocrine resistance in estrogen receptor-positive (ER+) breast cancer. The molecular mechanisms linking HER2 transactivation by HRG-bound HER3 to the acquisition of a hormo...

詳細記述

保存先:
書誌詳細
出版年:Int J Mol Sci
主要な著者: Papadimitropoulou, Adriana, Vellon, Luciano, Atlas, Ella, Steen, Travis Vander, Cuyàs, Elisabet, Verdura, Sara, Espinoza, Ingrid, Menendez, Javier A., Lupu, Ruth
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2020
主題:
Brief Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589856/
https://ncbi.nlm.nih.gov/pubmed/33086721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207737
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料